CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
Aequor redefines what ‘supply chain’ means during crisis
Dec 13, 2021
As a small biotech company, Aequor needs a reliable supply of chemicals and supplies. They lease lab space in an incubator setting. And in that lab, they develop custom product..
Read More Nano PharmaSolutions will opt for air freight as their new tech floats in Los Angeles harbor
Dec 13, 2021
Nano PharmaSolutions (NPS) developed an enabling technology to improve the solubility of small molecule drugs for both new chemical compounds and already approved drugs. Its unique nanosizing method involves evaporating..
Read More Catalent’s New Normal: How COVID-19 impacted the Supply Chain
Dec 13, 2021
Featured Expert: Melissa Buchanan, Director, Supply Chain, Catalent Biologics The pandemic has touched almost every aspect of our lives, and the pharmaceutical industry had to adapt quickly to continue to..
Read More How Cedars-Sinai Health System is navigating shortages during the global supply chain crisis
Dec 13, 2021
With unprecedented global supply chain challenges, any organization reliant on products and supplies has felt the impact over the last several months. These challenges have further affected healthcare providers already..
Read More Corning Life Sciences ramps up manufacturing, invests millions to reduce shortages
Dec 13, 2021
Across the industry, manufacturers and suppliers are working to fulfill orders of at least double the volumes seen before COVID-19. Corning Life Sciences has seen orders grow by 200-percent. Demand..
Read More Confronted with shortage of media bags, Nucleus Biologics started designing and manufacturing their own
Dec 13, 2021
Prior to the COVID-19 pandemic, the biologics revolution had already taken a significant toll on the global biologics supply chain–particularly due to the rapid growth of the cell and gene..
Read More